Tamro Group - SWOT Analysis company profile is the essential source for top-level company data and information. Tamro Group - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Tamro Group (Tamro), a wholly owned subsidiary of PHOENIX group, is engaged in the retail and wholesale distribution of pharmaceuticals and health care products. The group operates in Norway, Estonia, Latvia, Lithuania, Poland, Finland, Sweden and Denmark. The group is headquartered in Vantaa, Finland and employed about 5,455 people as of January 31, 2011. The group recorded revenues of E4,386.9 million* (approximately $5,788.6 million) during the financial year ended January 2011 (FY2011), an increase of 7.7% over FY2010. The operating profit of the group was E224.4 million (approximately $296.1 million) during FY2011, an increase of 45.3% over FY2010. The net profit was E146.2 million (approximately $192.9 million) in FY2010, an increase of 55% over FY2010. * From FY2011, the group has started reporting its financials in accordance with International Financial Reporting Standards (IFRS).
Scope of the Report
Provides all the crucial information on Tamro Group required for business and competitor intelligence needs
Contains a study of the major internal and external factors affecting Tamro Group in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Tamro Group
Data is supplemented with details on Tamro Group history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Tamro Group
Reasons to Purchase
Support sales activities by understanding your customers’ businesses better
Understand prospective partners and suppliers
Keep fully up to date on your competitors’ business structure, strategy and prospects
Obtain the most up to date company information available